Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir.
暂无分享,去创建一个
Shikha Lohan | Sarwar Beg | Babita Garg | Bhupinder Singh | S. Beg | Bhupinder Singh | O. Katare | O P Katare | Shikha Lohan | Babita Garg
[1] Amit Jain,et al. Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir. , 2013, Nanomedicine.
[2] W. Pan,et al. Preparation and Evaluation of Self-Microemulsifying Drug Delivery System Containing Vinpocetine , 2009, Drug development and industrial pharmacy.
[3] O. Abdallah,et al. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. , 2009, International journal of pharmaceutics.
[4] S. Singh,et al. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization , 2010, Drug development and industrial pharmacy.
[5] A. Mitra,et al. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. , 2011, Life sciences.
[6] Bhupinder Singh,et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. , 2009, Critical reviews in therapeutic drug carrier systems.
[7] P. Ravi,et al. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation , 2014, The Journal of pharmacy and pharmacology.
[8] Ashok Kumar,et al. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. , 2015, Colloids and surfaces. B, Biointerfaces.
[9] Saranjit Singh,et al. A Comprehensive Computer Program For The Study Of Drug Release Kinetics From Compressed Matrices , 1998 .
[10] F. Shakeel,et al. Effect of Labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion. , 2009, Die Pharmazie.
[11] Xiangliang Yang,et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] M. Khan,et al. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system , 2008, AAPS PharmSciTech.
[13] Ying Chen,et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. , 2008, Biological & pharmaceutical bulletin.
[14] Garill Coles,et al. Using failure mode effects and criticality analysis for high-risk processes at three community hospitals. , 2005, Joint Commission journal on quality and patient safety.
[15] R. Ghosh,et al. Recent advances in antiretroviral drugs , 2011, Expert opinion on pharmacotherapy.
[16] Bhupinder Singh,et al. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. , 2012, Colloids and surfaces. B, Biointerfaces.
[17] Sarwar Beg,et al. Recent advances in self-emulsifying drug delivery systems (SEDDS). , 2014, Critical reviews in therapeutic drug carrier systems.
[18] Bhupinder Singh,et al. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects , 2011, Expert opinion on drug delivery.
[19] Hoetelmans Rm. Sanctuary sites in HIV-1 infection. , 1998 .
[20] R. Hoetelmans. Sanctuary sites in HIV-1 infection. , 1998, Antiviral therapy.
[21] Gang Cheng,et al. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. , 2008, Drug discovery today.
[22] M. Rizwan,et al. Nanoemulsion Components Screening and Selection: a Technical Note , 2009, AAPS PharmSciTech.
[23] Steven W. Booth,et al. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy , 1995 .
[24] Johnson Lin,et al. BMC Infectious Diseases BioMed Central Research article , 2009 .
[25] A. Müllertz,et al. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[26] A. Date,et al. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. , 2010, Nanomedicine.
[27] Gordon L. Amidon,et al. Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.
[28] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[29] F. Sayyad,et al. Design and development of liquisolid compact of candesartan cilexetil to enhance dissolution , 2013 .
[30] A. Mccarthy. Development , 1996, Current Opinion in Neurobiology.
[31] P. Chattopadhyay,et al. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique , 2014, Archives of pharmacal research.
[32] T. Garg,et al. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. , 2015, International journal of pharmaceutics.
[33] E Williams,et al. The use of failure mode effect and criticality analysis in a medication error subcommittee. , 1994, Hospital pharmacy.
[34] C. Destache,et al. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1 , 2009, BMC infectious diseases.
[35] Koziel Mj. The immunopathogenesis of HBV infection. , 1998 .
[36] Sarfaraz Niazi,et al. Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.
[37] Martin Werle,et al. Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps , 2007, Pharmaceutical Research.
[38] Ming Yao,et al. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats , 2003, Archives of pharmacal research.
[39] E. Souto,et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[40] Chia-Chun Lin,et al. Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates. , 2008, Journal of the Formosan Medical Association = Taiwan yi zhi.
[41] J. Drewe,et al. Comparison of cyclosporin A absorption from LCT and MCT solutions following intrajejunal administration in conscious dogs. , 1996, Journal of pharmaceutical sciences.
[42] L. Endrenyi,et al. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence. , 1991, International journal of clinical pharmacology, therapy, and toxicology.
[43] Christel A. S. Bergström,et al. Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients , 2013, Pharmaceutical Research.
[44] B. Padhi,et al. Development and Pharmacokinetic Evaluation of Industrially Viable Self-microemulsifying Drug Delivery Systems (SMEDDS) for Terbinafine. , 2016, Current drug delivery.